Ardelyx, Inc. (NASDAQ:ARDX) Forecasted to Earn Q2 2024 Earnings of $0.01 Per Share

Ardelyx, Inc. (NASDAQ:ARDX – Get Rating) – Equities researchers at Wedbush issued their Q2 2024 EPS estimates for Ardelyx in a note issued to investors on Thursday, May 4th. Wedbush analyst L. Chico expects that the biopharmaceutical company will post earnings of $0.01 per share for the quarter. Wedbush has a “Outperform” rating and a […]

Related Keywords

Michael Raab ,Nasdaq ,Securities Exchange Commission ,Mirae Asset Global Investments Co ,Sargent Investment Group ,Ardelyx Inc ,Jump Financial ,Barclays Plc ,Cookson Peirce Co ,Get Rating ,Asset Global Investments ,Investment Group ,Exchange Commission ,Ardelyx Daily ,Ardelyx ,Nasdaq Ardx ,Cardx ,Medical ,Earnings Estimates ,Wedbush ,